by Yannis Natsis | Nov 20, 2017 | Universal Access and Affordable Medicines | Publications
According to the European Medicines Agency (EMA), “Scientific advice (SA) is when the Agency gives advice to a developer on the appropriate tests and studies in the development of a medicine. This is designed to facilitate the development and availability of...
by Yannis Natsis | Sep 27, 2017 | Universal Access and Affordable Medicines | Publications
DOWNLOAD THE REFLECTION PAPER In 2015, the Dutch and Belgian Ministers of Health signed a historic declaration of intent to jointly negotiate with the pharmaceutical sector on the price and reimbursement of some medicines. Since then, the cooperation has been joined...
by Giulia Vettore | May 4, 2017 | Universal Access and Affordable Medicines | Publications
Click on the button below to read EPHA’s response to the OECD online consultation on sustainable access to innovative therapies. Please note that the consultation response included EPHA’s Briefing Will fast-tracking new medicines improve affordability? DOWNLOAD...
by Yannis Natsis | Jan 18, 2017 | Universal Access and Affordable Medicines | Publications
Click on the button below to read EPHA’s respose to the Public consultation on strengthening EU cooperation on Health Technology Assessment (HTA). Download the Consultation Response ‘GOOD FENCES MAKE GOOD NEIGHBORS’: The European Public Health Alliance called on...
by Yannis Natsis | May 30, 2016 | Universal Access and Affordable Medicines, Universal Access and Affordable Medicines | Publications
This briefing is a response to an article published on May 12 2016 by four influential European regulators including the leadership of the European Medical Agency (EMA), as well as the Director of the Dutch Medicines Agency, addressing the issue of the...
by Yannis Natsis | May 26, 2016 | Universal Access and Affordable Medicines | Publications
A prominent group of nine leading professors and scientists have written a strongly worded letter to the European Medicines Agency raising serious concerns over the ongoing ’Adaptive Pathways’ pilot project. The pilot, due to be evaluated by June, seeks to accelerate...
